0001384101-24-000047.txt : 20240402 0001384101-24-000047.hdr.sgml : 20240402 20240402161753 ACCESSION NUMBER: 0001384101-24-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EASTHAM KARIN CENTRAL INDEX KEY: 0001231845 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 24814453 MAIL ADDRESS: STREET 1: C/O BURNHAM INSTITUTE FOR MEDICAL RESEAR STREET 2: 10901 N. TORREY PINES ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wk-form4_1712089048.xml FORM 4 X0508 4 2024-04-01 0 0001384101 VERACYTE, INC. VCYT 0001231845 EASTHAM KARIN 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Common Stock 2024-04-01 4 M 0 10000 13.19 A 43125 D Common Stock 2024-04-01 4 S 0 10000 21.6528 D 33125 D Stock Option (right to buy) 13.19 2024-04-01 4 M 0 10000 13.19 D 2024-05-20 Common Stock 10000 0 D The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 18, 2022. Represents weighted average sales price. Sale prices for the transactions range from $21.45 to $22.09. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The option is fully vested. /s/ Jonathan Wygant as attorney-in-fact 2024-04-02